Table 1 Characteristics of the patients (N = 60)
Variable | N | % |
|---|---|---|
Ages, yrs, mean ± SD (IQR) | 44.1 ± 13.8 (33–54) | – |
≥ 45 | 29 | 48.3 |
≥ 55 | 14 | 23.3 |
Sex, male/female | 18/42 | 30.0/70.0 |
BMI | 23.1 ± 3.7 | |
NG | 24 | 40.0 |
HD | 8 | 13.3 |
Hypertension | 5 | 8.3 |
Diabetes | 3 | 5.0 |
Hyperthyroidism | 5 | 8.3 |
Hypothyroidism | 0 | 0 |
Tumor size (primary), mm | ||
Mean ± SD (IQR) | 21.7 ± 14.3 (10.75–22.25) | |
> 40 mm | 7 | 11.7 |
Multifocality (primary) | 11 | 18.3 |
Bilaterality (primary) | 8 | 13.3 |
TgAb positive (> 115U/mL) | 8 | 13.3 |
TNM stage (primary) | ||
Tx/T1/T2/T3/T4 | 8/11/6/16/19 | 13.3/18.3/10.0/26.7/31.7 |
Nx/N0/N1a/N1b | 0/11/12/37 | 0/18.3/20.0/61.7 |
Mx/M0/M1 | 1/59/0 | 1.7/98.3/0 |
Surgical strategy | ||
iCND/bCND | 4/15 | 6.7/25.0 |
iCND + iLND | 7 | 11.7 |
bCND + iLND | 24 | 40.0 |
bCND + bLND | 10 | 16.7 |
Harvested LNs | 33.0 ± 20.8 | |
Metastatic LNs | 8.5 ± 8.2 | |
The ratio of metastatic LNs % | 29.5 ± 23.1 | |
RAI Administration | 49 | 81.7 |
Central LNs recurrence | 19 | 31.7 |
Lateral LNs recurrence | 36 | 60.0 |
Central & lateral LNs recurrence | 5 | 8.3 |
Diameters of recurrent LNs, mm, Mean ± SD (IQR) | 18.7 ± 12.9 (10.75–22.00) | |
Extranodal extension | 20 | 33.3 |